tiprankstipranks
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
US Market
ADAPY
Adaptimmune Therapeutics
RESEARCH TOOLSreports
Want to see ADAPY full AI Analyst Report?

Adaptimmune Therapeutics (ADAPY) Ratios

1,251 Followers

Adaptimmune Therapeutics Ratios

ADAPY's free cash flow for Q2 2025 was $0.82. For the 2025 fiscal year, ADAPY's free cash flow was decreased by $ and operating cash flow was $-2.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.52 2.92 2.85 3.96 6.64
Quick Ratio
 1.29 2.80 2.85 3.96 6.64
Cash Ratio
 0.51 1.41 1.98 1.67 2.40
Solvency Ratio
 -0.72 -0.25 -0.43 -0.65 -0.57
Operating Cash Flow Ratio
 -2.63 -1.13 -1.94 -2.20 0.17
Short-Term Operating Cash Flow Coverage
 -30.03 -15.55 0.00 -51.97 4.62
Net Current Asset Value
$ -123.48M$ -45.95M$ -35.55M$ 8.33M$ 151.87M
Leverage Ratios
Debt-to-Assets Ratio
 0.37 0.30 0.09 0.07 0.05
Debt-to-Equity Ratio
 -0.69 6.26 0.64 0.28 0.12
Debt-to-Capital Ratio
 -2.19 0.86 0.39 0.22 0.11
Long-Term Debt-to-Capital Ratio
 -0.57 0.81 0.00 0.00 0.00
Financial Leverage Ratio
 -1.84 20.76 7.15 4.02 2.28
Debt Service Coverage Ratio
 -15.08 -6.98 0.00 -57.95 -67.44
Interest Coverage Ratio
 -32.82 -20.54 0.00 0.00 0.00
Debt to Market Cap
 11.39 0.40 0.00 0.01 <0.01
Interest Debt Per Share
 0.20 0.31 0.13 0.14 0.16
Net Debt to EBITDA
 -0.17 0.32 0.93 0.55 0.80
Profitability Margins
Gross Profit Margin
86.02%99.96%83.65%-370.48%-1706.64%
EBIT Margin
-598.34%-35.89%-228.99%-595.51%-2638.58%
EBITDA Margin
-566.05%-29.58%-212.67%-573.13%-2531.78%
Operating Profit Margin
-618.34%-38.62%-228.99%-603.97%-2638.58%
Pretax Profit Margin
-607.65%-37.78%-186.68%-600.26%-2558.12%
Net Profit Margin
-629.09%-39.78%-188.90%-609.46%-2570.99%
Continuous Operations Profit Margin
-626.24%-39.79%-188.90%-609.46%-2570.99%
Net Income Per EBT
103.53%105.27%101.19%101.53%100.50%
EBT Per EBIT
98.27%97.83%81.52%99.39%96.95%
Return on Assets (ROA)
-116.46%-28.79%-40.29%-50.30%-33.67%
Return on Equity (ROE)
472.78%-597.64%-288.19%-202.08%-76.76%
Return on Capital Employed (ROCE)
-189.00%-37.90%-65.79%-62.01%-39.86%
Return on Invested Capital (ROIC)
-169.54%-36.03%-64.14%-60.76%-39.41%
Return on Tangible Assets
-119.96%-29.25%-40.34%-50.37%-33.74%
Earnings Yield
-13243.54%-52.10%-71.41%-70.30%-27.06%
Efficiency Ratios
Receivables Turnover
 0.84 11.14 1.28 0.71 0.18
Payables Turnover
 0.36 <0.01 1.21 26.87 13.69
Inventory Turnover
 0.30 <0.01 0.00 0.00 0.00
Fixed Asset Turnover
 0.52 3.48 0.84 0.38 0.12
Asset Turnover
 0.19 0.72 0.21 0.08 0.01
Working Capital Turnover Ratio
 0.62 1.38 0.37 0.10 0.02
Cash Conversion Cycle
 651.32 -7.12K -16.88 498.49 1.99K
Days of Sales Outstanding
 436.10 32.77 284.09 512.07 2.02K
Days of Inventory Outstanding
 1.23K 38.17K 0.00 0.00 0.00
Days of Payables Outstanding
 1.02K 45.32K 300.97 13.58 26.66
Operating Cycle
 1.67K 38.20K 284.09 512.07 2.02K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.51 -0.29 -0.70 -0.88 0.07
Free Cash Flow Per Share
 -0.52 -0.30 -0.72 -1.06 0.01
CapEx Per Share
 <0.01 0.01 0.02 0.18 0.06
Free Cash Flow to Operating Cash Flow
 1.01 1.04 1.03 1.21 0.18
Dividend Paid and CapEx Coverage Ratio
 -55.31 -26.91 -28.87 -4.77 1.22
Capital Expenditure Coverage Ratio
 -55.31 -26.91 -28.87 -4.77 1.22
Operating Cash Flow Coverage Ratio
 -2.79 -0.99 -5.58 -6.14 0.42
Operating Cash Flow to Sales Ratio
 -5.61 -0.41 -2.34 -5.22 1.74
Free Cash Flow Yield
-11867.05%-55.86%-91.41%-72.87%0.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.02 -1.92 -1.40 -1.42 -3.70
Price-to-Sales (P/S) Ratio
 0.11 0.76 2.65 8.67 95.02
Price-to-Book (P/B) Ratio
 -0.04 11.47 4.04 2.87 2.84
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.02 -1.79 -1.09 -1.37 299.93
Price-to-Operating Cash Flow Ratio
 -0.02 -1.86 -1.13 -1.66 54.46
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.04 0.03 0.00 -0.28
Price-to-Fair Value
 -0.04 11.47 4.04 2.87 2.84
Enterprise Value Multiple
 -0.18 -2.26 -0.32 -0.97 -2.95
Enterprise Value
 23.77M 118.98M 40.70M 150.41M 459.79M
EV to EBITDA
 -0.17 -2.26 -0.32 -0.97 -2.95
EV to Sales
 0.98 0.67 0.68 5.54 74.77
EV to Free Cash Flow
 -0.17 -1.57 -0.28 -0.88 236.03
EV to Operating Cash Flow
 -0.18 -1.63 -0.29 -1.06 42.85
Tangible Book Value Per Share
 -0.28 0.03 0.19 0.51 1.32
Shareholders’ Equity Per Share
 -0.27 0.05 0.20 0.51 1.32
Tax and Other Ratios
Effective Tax Rate
 <0.01 -0.05 -0.01 -0.02 >-0.01
Revenue Per Share
 0.09 0.71 0.30 0.17 0.04
Net Income Per Share
 -0.58 -0.28 -0.57 -1.03 -1.01
Tax Burden
 1.04 1.05 1.01 1.02 1.01
Interest Burden
 1.02 1.05 0.82 1.01 0.97
Research & Development to Revenue
 3.76 0.84 2.10 4.70 18.07
SG&A to Revenue
 2.58 0.46 1.19 2.33 9.32
Stock-Based Compensation to Revenue
 0.28 0.07 0.20 0.67 3.35
Income Quality
 0.91 1.03 1.24 0.86 -0.07
Currency in USD